Five vascular endothelial growth factor receptor (VEGFR) ligands (VEGF-A,-B,–C,-D, and
placental growth factor [PlGF]) constitute the VEGF family. VEGF-A binds VEGF receptors 1 …

The role of photocoagulation in retinal vein occlusion (RVO) has been studied since 1974.
The most serious complications of central retinal vein occlusion (CRVO) and branch retinal …

The high prevalence of cardiovascular disease particularly in the elderly population is
associated with retinal vascular disease. Retinal vein occlusions represent severe …

Importance The comparative clinical effectiveness of ranibizumab, aflibercept, and
bevacizumab for the management of macular edema due to central retinal vein occlusion …

Retinal vein occlusion represents the second leading cause of retinal vascular disorders,
with a uniform sex distribution worldwide. A thorough evaluation of cardiovascular risk …

Vascular endothelial growth factors (VEGFs) are key mediator of retinal and choroidal
neovascularization as well as retinal vascular leakage leading to macular edema. As such …

Purpose: To study a novel and fast optical coherence tomography (OCT) device for home-
based monitoring in age-related macular degeneration (AMD) in a small sample yielding …

Background Intravitreal injections are a mandatory treatment for macular edema due to
nAMD, DME and RVO. These chronic diseases usually need chronic treatment using …

Abstract Background Suprachoroidal Drug Delivery has emerged in recent years as a novel
promising approach, which may help address the clinical unmet needs in the management …

This systematic review assessed the long-term outcomes for patients treated with intravitreal
antivascular endothelial growth factor or dexamethasone for macular oedema (MO) …